KCNH5: A Potential Drug Target for GABA-Related Conditions (G27133)

Target Name: KCNH5

NCBI ID: G27133

KCNH5

KCNH5: A Potential Drug Target for GABA-Related Conditions

KCNH5, also known as KCNH5 variant 1, is a protein that is expressed in the brain and is known for its role in the regulation of neuronal excitability. Several studies have suggested that KCNH5 may be a drug target or biomarker, and research into its potential therapeutic uses has ongoing.

The neurotransmitter GABA is known for its role in the regulation of neural activity and is involved in a wide range of physiological processes, including sleep, anxiety, and depression. The GABAergic system is a complex network of neurons that are involved in the regulation of GABA levels and function. KCNH5 is a key component of the GABAergic system and is involved in the regulation of GABA levels in the brain.

KCNH5 is a transmembrane protein that is expressed in the brain and is primarily localized to the postsynaptic terminal of neurons. It is composed of four structural domains: an N-terminus, a catalytic domain, a transmembrane region, and a C-terminus. The N-terminus of KCNH5 contains a putative GABA-binding site, which is thought to be the site at which KCNH5 interacts with GABA.

Several studies have suggested that KCNH5 may be a drug target or biomarker because of its involvement in the regulation of GABA levels. GABA is known for its ability to inhibit neurotransmitter release and modulate the activity of neurons, and it is thought to play a key role in the regulation of neural activity. Several studies have shown that drugs that increase GABA levels or inhibit GABA receptors have therapeutic benefits for a wide range of conditions, including anxiety, depression, and neurodegenerative diseases.

One potential mechanism by which KCNH5 may be involved in the regulation of GABA levels is through its interaction with GABA receptors. GABA receptors are a family of transmembrane proteins that are involved in the regulation of GABA levels and function. There are several different types of GABA receptors, including GABA伪1, GABA伪2, GABA尾, and GABA纬. These receptors are involved in the regulation of GABA levels and function, and they are thought to play a key role in the regulation of neural activity.

KCNH5 has been shown to interact with several different GABA receptors, including GABA伪1, GABA伪2, and GABA尾. These interactions may be important for the regulation of GABA levels and function in the brain. For example, studies have shown that inhibition of GABA伪2 receptors can increase GABA levels in the brain, while inhibition of GABA尾 receptors can decrease GABA levels in the brain. These findings suggest that GABA伪2 and GABA尾 receptors may be involved in the regulation of GABA levels in the brain, and that inhibition of these receptors may be a potential therapeutic approach for the treatment of GABA-related conditions.

In addition to its potential role in the regulation of GABA levels, KCNH5 has also been shown to be involved in the regulation of other physiological processes in the brain. For example, studies have shown that KCNH5 is involved in the regulation of neuronal excitability and that changes in its expression levels can affect the activity of neurons. These findings suggest that KCNH5 may be an important target for the development of new therapeutic approaches for a wide range of neurological conditions.

Overall, while more research is needed to fully understand the role of KCNH5 in the regulation of GABA levels and its potential therapeutic uses, it is clear that it is an important protein that is involved in the regulation of neural activity. Further studies are needed to determine the full extent of its involvement and its potential as a drug target or biomarker.

Protein Name: Potassium Voltage-gated Channel Subfamily H Member 5

Functions: Pore-forming (alpha) subunit of voltage-gated potassium channel. Elicits a non-inactivating outward rectifying current. Channel properties may be modulated by cAMP and subunit assembly

The "KCNH5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNH5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets